New generic asthma inhaler put to the test in major trial
NCT ID NCT07223294
Summary
This study aims to see if a new, more affordable generic version of a common asthma inhaler works just as well and is as safe as the original brand-name product. It will involve about 1,430 adults with asthma who will use one of the inhalers or a placebo (dummy treatment) for four weeks. Researchers will measure how well the participants' lungs work to compare the two inhalers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sandoz Investigational Site
Cullman, Alabama, 35055, United States
-
Sandoz Investigational Site
Bradenton, Florida, 34208, United States
-
Sandoz Investigational Site
Leesburg, Florida, 34748, United States
-
Sandoz Investigational Site
Orlando, Florida, 32789, United States
-
Sandoz Investigational Site
St Louis, Missouri, 63141, United States
-
Sandoz Investigational Site
Raleigh, North Carolina, 27607, United States
Conditions
Explore the condition pages connected to this study.